Regional investment is a top priority for IDA Ireland. IDA CEO Martin Shanahan said: “This is very welcome news. Our Ireland presence is essential for Beckman Coulter to achieve our vision of advancing healthcare for every person. The calibre of the local workforce and the excellent support we receive from the community really sets this site apart. Piers Devereux, VP of operations for Beckman Coulter, said, “We are excited to build out our site here in County Clare. This expansion now places Beckman Coulter to the forefront of the biomedical testing industry and the investment made by the company also allows for ongoing growth of current product streams.” This is a great boost for Clare and the Mid West Region.
As Minister for Employment I warmly welcome the creation of 70 additional jobs over the next two to three years. Minister of State for Employment and Small Business Pat Breen TD said, “Beckman Coulter’s expansion is a great win for County Clare, the Irish Government and the IDA. Planning permission has been granted for the new facilities by Clare County Council and construction is expected to commence in the first quarter of 2018. The new expansion will add an additional 6,700sq. The expansion will provide capacity for two new product streams at the Clare site, and will also provide for the ongoing growth of the current product streams. Work carried out currently on the site includes the development, manufacture and support of reagents (mixtures for use in chemical analysis) for clinical chemistry, immunochemistry and haematology product lines. metre site at Lismeehan in County Clare is a strategic site for the global Beckman Coulter Diagnostics business, with 330 people working there. The project is supported by the Irish Government through IDA Ireland. By innovating new processes and technologies, we’re challenging conventional wisdom to develop the best, most widely trusted laboratory solutions available in the market today.BECKMAN Coulter, based in Lismeehan, O’Callaghan’s Mills is to create 70 jobs over the next two to three years as it just announced expansion plans today.īeckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing and has revealed it is expanding the company’s development and manufacturing facility at Lismeehan. In the life sciences, researchers use Beckman Coulter’s precision instruments to study complex biological problems, including causes of disease and potential new treatments. Our team of experts dedicates the time and energy to understand the complexity of research for laboratory customers in a wide variety of settings: universities, government, biotechnology and pharmaceutical companies, hospitals, and commercial laboratories. We have a vital role: our focus on innovation, reliability and efficiency has led us to become the partner of choice for clinical, research and industrial customers around the globe. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient care. At Beckman Coulter, we are dedicated to advancing and optimizing the laboratory.